Latest immunotherapy news
FDA Approves Zynyz as First-Line Treatment for Advanced Anal Cancer
posted May 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer
posted May 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Peanut Oral Immunotherapy Efficacious in Allergic Adults
posted May 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
posted April 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Obesity Linked to Early-Onset Cancer Risk in Young Adults .jpg)
Recurrent Visual Field Progression Happens for 1 in 4 With Glaucoma .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers Related Articles
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
